A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Risperidone (Primary)
- Indications Alzheimer's disease; Dementia; Vascular dementia
- Focus Therapeutic Use
- Sponsors Janssen
- 25 Jul 2016 New trial record
- 07 Jul 2016 Results of pooled analysis from 6 trials (USA-63, INT-24, AUS-5, USA-232, BEL-14 and INT-83) published in the British Journal of Psychiatry